Literature DB >> 11747728

Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

A Hakanen1, P Kotilainen, P Huovinen, H Helenius, A Siitonen.   

Abstract

During 1995 to 1999, we collected 1,210 Salmonella isolates; 629 were from Finnish travelers returning from abroad. These isolates were tested for susceptibility by determining MICs to ciprofloxacin, nalidixic acid, and seven additional antimicrobial agents. From 1995 to 1999, the annual proportion of reduced ciprofloxacin susceptibility (MIC > 0.125 microg/mL) among all travelers' isolates increased from 3.9% to 23.5% (p<0.001). The increasing trend was outstanding among the isolates from Southeast Asia; isolates from Thailand alone increased from 5.6% to 50.0% (p<0.001). The reduced fluoroquinolone susceptibility was nonclonal in character and significantly associated with multidrug resistance. A point mutation in the quinolone resistance-determining region of gyrA was present in all isolates with reduced susceptibility. These data provide further evidence for the rapid spread of multidrug-resistant pathogens from one continent to another.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747728      PMCID: PMC2631904          DOI: 10.3201/eid0706.010613

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  34 in total

1.  Reduced susceptibility to quinolones in Salmonella typhi acquired in Europe: a clinical failure of treatment.

Authors:  Zoe Le Lostec; S. Fegueux; P. Jouve; M. Cheron; P. Mornet; A. Boisivon
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

2.  An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

Authors:  K Mølbak; D L Baggesen; F M Aarestrup; J M Ebbesen; J Engberg; K Frydendahl; P Gerner-Smidt; A M Petersen; H C Wegener
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

3.  Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.

Authors:  M K Glynn; C Bopp; W Dewitt; P Dabney; M Mokhtar; F J Angulo
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

4.  Oxolinic acid treatment of urinary-tract infections.

Authors:  D J D'Alessio; V M Olexy; G G Jackson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

5.  Acalculous nontyphoidal salmonellal cholecystitis requiring surgical intervention despite ciprofloxacin therapy: report of three cases.

Authors:  B McCarron; W C Love
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

6.  Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones.

Authors:  Odile Launay; Jean-Claude Nguyen Van; Annie Buu-Hoï; J. F. Acar
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

7.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.

Authors:  J Wain; N T Hoa; N T Chinh; H Vinh; M J Everett; T S Diep; N P Day; T Solomon; N J White; L J Piddock; C M Parry
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

8.  Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs.

Authors:  J C Brown; C J Thomson; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

9.  Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.

Authors:  C W Hoge; L Bodhidatta; C Tungtaem; P Echeverria
Journal:  Int J Epidemiol       Date:  1995-12       Impact factor: 7.196

10.  Emerging quinolone-resistant Salmonella in the United States.

Authors:  H Herikstad; P Hayes; M Mokhtar; M L Fracaro; E J Threlfall; F J Angulo
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

View more
  28 in total

1.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  In vitro activity of azithromycin against nontyphoidal Salmonella enterica.

Authors:  Marianne Gunell; Pirkko Kotilainen; Jari Jalava; Pentti Huovinen; Anja Siitonen; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

3.  Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.

Authors:  Jennifer E Stevenson; Kathryn Gay; Timothy J Barrett; Felicita Medalla; Tom M Chiller; Frederick J Angulo
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

4.  Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.

Authors:  Marianne Gunell; Mark A Webber; Pirkko Kotilainen; Andrew J Lilly; Jonathan M Caddick; Jari Jalava; Pentti Huovinen; Anja Siitonen; Antti J Hakanen; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

5.  Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.

Authors:  Roberto Cabrera; Joaquím Ruiz; Francesc Marco; Inés Oliveira; Margarita Arroyo; Ana Aladueña; Miguel A Usera; M Teresa Jiménez De Anta; Joaquím Gascón; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination.

Authors:  Antti Hakanen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen; Pirkko Kotilainen
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

7.  Recent Advances and New Challenges in Travel Medicine.

Authors:  Lin H. Chen; Mary E. Wilson
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663

8.  Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.

Authors:  Marianne M Lindgren; Pirkko Kotilainen; Pentti Huovinen; Saija Hurme; Susanna Lukinmaa; Mark A Webber; Laura J V Piddock; Anja Siitonen; Antti J Hakanen
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

9.  Drug-resistant nontyphoidal Salmonella bacteremia, Thailand.

Authors:  Wanla Kulwichit; Tanittha Chatsuwan; Chudaachhara Unhasuta; Chaiwat Pulsrikarn; Aroon Bangtrakulnonth; Anan Chongthaleong
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

10.  Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones.

Authors:  Kabir O Akinyemi; Babajide S Bamiro; Akitoye O Coker
Journal:  J Health Popul Nutr       Date:  2007-09       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.